Intest Corp Dossier - Source-backed chat

Intest Corp

INTTNYSE

SectorInformation Technology

IndustrySemiconductor Materials & Equipment

Beta (adjusted)1.36

Intrinsic Value $11.08median of 3 methodsbased on filings through 31 Mar 2026

Market Price $11.97Price as of 1 Oct 2026

Near fair valueIntrinsic value is 7% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $153.5M

Enterprise Value $149.2M

Shares Outstanding 12.4M diluted

Moat Rating None

Next Earnings Date4 Nov 2026

Last ex-dividend6 Dec 2012

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

inTest Corp (INTT) is successfully executing its diversification strategy, reducing its historical reliance on cyclical semiconductor capital spending by expanding into high-growth markets such as Automotive/EV, Defense/Aerospace, and Life Sciences. Under the leadership of newly appointed CEO Rich Rogoff, the company is shifting from a decentralized holding structure to an integrated, scalable platform. This transition is driving operational synergies, margin expansion, and robust top-line growth, as evidenced by a strong Q1 2026 performance where revenue grew 27.2% year-over-year to $33.9 million. With raised full-year 2026 revenue guidance and early signs of a back-end semiconductor recovery, INTT offers an attractive risk-reward profile for small-cap growth investors.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets3 analysts · as of 18 Aug 2026

Low · most bearish analyst$15.00

Mean target$19.33

High · most bullish analyst$22.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The bear case reflects a prolonged downturn or stagnation in semiconductor capital spending, coupled with macroeconomic headwinds that slow down automotive EV programs and industrial capital expenditures. Integration friction or higher-than-expected operating expenses from recent acquisitions compress margins, keeping net earnings flat. Under this scenario, revenue growth slows to the low single digits, and the stock tests its key support levels.

Base CaseCentral scenario

The base case assumes steady execution of the VISION 2030 strategy, with non-semiconductor segments (Auto/EV, Defense, and Life Sciences) maintaining double-digit growth. The integration of Alfamation continues to unlock cross-selling opportunities in automotive test programs. Operating margins expand back toward 10% as the company leverages its leaner cost structure and absorbs fixed costs. The semiconductor market experiences a modest, gradual recovery in the second half of 2026, allowing inTest to achieve the upper end of its raised full-year revenue guidance of $130 million to $135 million.

Bull CaseUpside scenario

The bull case centers on inTEST's deeply discounted valuation relative to peers (trading at ~1x sales vs. peers at 3-5x), its diversification beyond cyclical semiconductors into high-growth automotive/EV, defense, and life sciences markets, and a potential earnings recovery to $1.50-$1.60 per share within two years, supporting a long-term $30 price target.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Successful diversification into resilient end-markets (Auto/EV, Defense/Aerospace, Life Sciences) reducing semiconductor cyclicality.
Transition to an integrated operating platform under CEO Rich Rogoff, unlocking operational synergies and cost efficiencies.
Strong balance sheet with $15.7 million in cash and substantial liquidity under credit facilities to support organic growth and targeted M&A.
Favorable product mix and volume leverage driving gross margin expansion (45.5% in Q1 2026).

Key Investment Risks

Slower-than-anticipated recovery in the semiconductor capital equipment market.
Integration risks and potential operational friction associated with recent acquisitions like Alfamation.
Customer concentration and sensitivity to macroeconomic cycles in the industrial and automotive sectors.

Thesis Invalidation Triggers

Sequential decline in quarterly order bookings below $28 million.
Failure to maintain gross margins above 43%, indicating pricing pressure or unfavorable product mix.
Significant delays or cancellations in major automotive model programs.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.